NYSE:WSTLife Sciences
West Pharmaceutical Services (WST) Raised Guidance, Is It Still 16% Undervalued?
Why West Pharmaceutical Services Stock Is Back In Focus After Q2
West Pharmaceutical Services (WST) is back on investors radar after reporting second quarter 2026 results, raising its full year revenue outlook and updating shareholders on recent buyback and dividend activity.
See our latest analysis for West Pharmaceutical Services.
At a latest share price of US$340.96, West Pharmaceutical Services has seen a 13.4% 90 day share price return and a 23.4% year to date share price return. The 1...